SAN DIEGO, Feb. 24, 2016 /PRNewswire/ -- Sequenom, Inc.
(NASDAQ: SQNM), a life sciences company committed to enabling
healthier lives through the development of innovative products and
services, today announced it will report financial results for the
fourth quarter 2015 after closing of the NASDAQ Global Market on
Wednesday, March 2, 2016.
A conference call hosted by Dr. Dirk van
den Boom, President and CEO, and other members of senior
management will take place on Wednesday,
March 2, 2016, at 5:00 p.m. ET
(2:00 p.m. PT) and will be webcast
live on the Sequenom Website.
Call participants should dial 877-883-0383 (U.S. / Canada) or 412-902-6506 (other countries).
Please use code 9189690. A telephonic replay will be available
through April 2, 2016 by dialing
877-344-7529 (US toll free), 855-669-9658 (Canada toll free), or 412-317-0088
(international toll), and entering the conference number
10081831.
The conference call webcast is also accessible through the
"Invest" section of the Sequenom Website at
www.sequenom.com/invest
About Sequenom
Sequenom, Inc. (NASDAQ: SQNM) is a pioneering genetic testing
company dedicated to women's health through the development of
innovative products and services. The Company serves patients
and physicians by providing early patient management
information. For more information, visit
www.sequenom.com.
About Sequenom Laboratories
Sequenom Laboratories, a CAP-accredited and CLIA-certified
molecular diagnostics laboratory, has developed a broad range of
laboratory tests, with a focus principally on prenatal care.
Branded under the names HerediT®, HerediT® UNIVERSAL, MaterniT®
GENOME, MaterniT21® PLUS, NextView®, SensiGene® and VisibiliT™,
these molecular genetic laboratory-developed tests provide early
patient management information for obstetricians, geneticists, and
maternal fetal medicine specialists. Sequenom Laboratories is
changing the landscape in genetic diagnostics using proprietary
cutting edge technologies. Visit www.laboratories.sequenom.com and
follow @SequenomLabs.
SEQUENOM®, HerediT®, MaterniT® GENOME, MaterniT21® PLUS,
NextView®, SensiGene®, VisibiliT™ and Sequenom Laboratories™ are
trademarks of Sequenom, Inc. All other trademarks and service marks
are the property of their respective owners.
Logo - http://photos.prnewswire.com/prnh/20040415/SQNMLOGO
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/sequenom-schedules-fourth-quarter-and-full-year-2015-results-conference-call-for-march-2-2016-300225063.html
SOURCE Sequenom, Inc.